Inflammation is a common inducer of numerous severe diseases such as
sepsis. The NF-κB signaling pathway plays a key role in the inflammatory process. Its activation promotes the release of pro-inflammatory mediators like
inducible nitric oxide synthase and
tumor necrosis factor alpha.
Peroxisome proliferator-activated receptor gamma (
PPAR-γ) inactivates
nuclear factor kappa B (NF-κB) and subsequently attenuates
inflammation.
Rhein, an agent isolated from rhubarb, has been known to have anti-inflammatory effects. However, its influence on
PPAR-γ remains largely unknown. In this study, an
inflammation model was constructed by stimulating RAW264.7 cells with
lipopolysaccharide.
Rhein was used as a therapeutic agent, while
rosiglitazone (
PPAR-γ activator) and
GW9662 (
PPAR-γ inhibitor) were used as disrupters for in depth studies. The results demonstrated that
rhein inhibits NF-κB activation and inflammatory factor release. However,
GW9662 significantly reduced this effect, indicating that
PPAR-γ is a critical mediator in the
rhein-mediated anti-inflammatory process. Additionally, positive modulation of
PPAR-γ expression and activity by
rosiglitazone correspondingly influenced the effects of
rhein on inflammatory factors and NF-κB expression. We also found that
rhein could enhance
PPAR-γ, NF-κB, and
histone deacetylase 3 (HDAC3) binding. These results indicate that
rhein exerts its anti-
inflammation function by regulating the PPAR-γ-NF-κB-HDAC3 axis.